FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG)…
Category: Trending
Oasis Aesthetics & Wellness Introduces Breakthrough Noninvasive Technologies for Brain Health, Facial Rejuvenation, and Body Sculpting
SUGAR LAND, Texas, March 26, 2026 /PRNewswire/ — Oasis Aesthetics & Wellness, an innovative health and…
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle…
Hartford HealthCare Announces Tender Offer for Outstanding Debt Securities
Hartford HealthCare Corporation (the “Corporation“) today announced that it has commenced a tender offer to purchase…
Webinar Series: Mastering risk adjustment essentials in 2026
Risk adjustment is a strategic, constantly evolving field at the heart of healthcare transformation, and 2026…
Best Creatine for Men (2026): iHerb Recognized for the Widest Selection of Creatine Supplements by Expert Consumers
NEW YORK, Jan. 26, 2026 /PRNewswire/ — Expert Consumers has recognized iHerb for offering the widest…
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis
Elanco’s second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S.…
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
SAN DIEGO, Nov. 25, 2025 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical…
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
— New North American logistics center will provide expanded distribution for CollPlant’s rhCollagen and BioInks as…
NORD Awards 2025 Seed Grants to Propel Breakthroughs in Rare Disease Research
Over $80K in Funding Supports Promising Studies Targeting Two Critically Underserved Conditions DANBURY, Conn., Sept. 8,…